Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors

被引：0
|
作者：
Ebbert, Patrick T.
Ragni, Margaret V.
Xavier, Frederico
Malec, Lynn M.
Seaman, Craig D.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3689
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Retrospective Observational Descriptive Study on the Effectiveness and Usage of Emicizumab and Antihemophilic Factor (recombinant), Fc Fusion Protein in Patients with Hemophilia A in the US
    Cockerham, Alex
    Wilson, Amanda
    Frick, Andrew
    Dasmahapatra, Pronabesh
    BLOOD, 2021, 138
  • [42] Eradication of factor viii inhibitors in patients with mild and moderate hemophilia A
    Kempton, Christine L.
    Allen, Geoff
    Hord, Jeffrey
    Kruse-Jarres, Rebecca
    Pruthi, Rajiv K.
    Walsh, Christopher
    Young, Guy
    Soucie, J. Michael
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 933 - 936
  • [43] Tolerance to factor VIII inhibitors in hemophilia a patients: A French twist
    Pascual, V
    Capra, JD
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (06): : 1357 - 1358
  • [44] Plasma-derived or recombinant factor VIII products and inhibitors in previously untreated patients with severe hemophilia
    van der Bom, Johanna G.
    Gouw, Samantha C.
    van den Berg, H. Marijke
    BLOOD, 2007, 110 (03) : 1074 - 1075
  • [45] Factor VIII inhibitors in patients with non-severe hemophilia
    Kempton, C. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 78 - 79
  • [46] Factor VIII inhibitors in hemophilia a patients with different treatment modalities
    Abdel-Halim, Afifi O.
    Abdul-Azeem, Argoon S.
    Abdel-Rahman, Ahmad Y.
    Thabet, N. M.
    Abdul-All, R. F.
    Mohamed, G. G.
    Thabet, A. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 100 - 100
  • [47] THE INCIDENCE OF FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A
    SCHWARZINGER, I
    LECHNER, K
    NIESSNER, H
    PABINGER, I
    HAEMOSTASIS, 1985, 15 (01) : 17 - 17
  • [48] The economic impact of factor VIII inhibitors in patients with hemophilia.
    Bohn, RL
    Aledort, LM
    Putnam, KG
    Ewenstein, BM
    Avorn, J
    BLOOD, 2000, 96 (11) : 434A - 435A
  • [49] Acquired hemophilia due to factor VIII inhibitors in 34 patients
    Bossi, P
    Cabane, J
    Ninet, J
    Dhote, R
    Hanslik, T
    Chosidow, O
    Jouan-Flahault, C
    Horellou, MH
    Leynadier, F
    Liozon, E
    Pouchot, J
    Robin, JP
    Sanderson, F
    Schaeffer, A
    Sicard, D
    Staikowsky, F
    Wechsler, B
    Zittoun, R
    AMERICAN JOURNAL OF MEDICINE, 1998, 105 (05): : 400 - 408
  • [50] Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
    Dumont, Jennifer A.
    Liu, Tongyao
    Low, Susan C.
    Zhang, Xin
    Kamphaus, George
    Sakorafas, Paul
    Fraley, Cara
    Drager, Douglas
    Reidy, Thomas
    McCue, Justin
    Franck, Helen W. G.
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    Pierce, Glenn F.
    Jiang, Haiyan
    BLOOD, 2012, 119 (13) : 3024 - 3030
12345